We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

120 hedge funds and large institutions have $215M invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q2 according to their latest regulatory filings, with 120 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $9.83M | Put options by funds: $9.7M

Holders
120
Holders Change
+120
Holders Change %
–
% of All Funds
3.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
120
Increased
–
Reduced
–
Closed
–
Calls
$9.83M
Puts
$9.7M
Net Calls
+$126K
Net Calls Change
+$126K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ASTX Hedge Fund Activity: Q2 2013 in Review

120 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q2 2013, worth a combined $215M.

Buyers outnumbered sellers: 120 funds opened new ASTX positions and 0 closed out — a net gain of 120 holders — while 0 added to existing stakes and 0 trimmed.

  • 120 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $215M of ASTEX PHARMACEUTICALS, INC COM stock for Q2 2013.
  • 120 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q2 2013 and 0 closed out, a net change of +120 holders.

Based on aggregated 13F filings for Q2 2013.